Product Information
TRIAMCINOLONE ACET 200 MG/5 ML is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $6.3832 per ML under NDC 00703024301. Its NADAC has been published 168 times since Jul 19, 2023.
FDA first approved this application on Oct 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
Teva Parenteral Medicines, Inc.NDC
00703024301
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209852FDA Approved
10/5/2018
TE Code
AB
On Market Since
8/29/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has been published 168 times since Jul 19, 2023, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3832 per ML |
|---|---|
| All-time high | $6.6713 (Apr 10, 2024) |
| All-time low | $3.9913 (Mar 19, 2025) |
| 52-week high | $6.4795 |
| 52-week low | $5.3107 |
| Median price | $5.9409 |
| Average price | $5.9006 |
| Largest weekly change | -30.7% (Mar 19, 2025) |
| Weeks tracked | 168 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Parenteral Medicines, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE ACET 200 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE ACET 200 MG/5 ML, manufactured by Teva Parenteral Medicines, Inc., is $6.3832 per ML (NDC 00703024301), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE ACET 200 MG/5 ML changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has declined 4.3%. It has been tracked across 168 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE ACET 200 MG/5 ML?
Since Jul 19, 2023, the NADAC for TRIAMCINOLONE ACET 200 MG/5 ML has ranged from a low of $3.9913 (Mar 19, 2025) to a high of $6.6713 (Apr 10, 2024), with a median of $5.9409 per ML.
Are there cheaper alternatives to TRIAMCINOLONE ACET 200 MG/5 ML?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE ACET 400 MG/10 ML, is $4.7820 per ML — about 25% below TRIAMCINOLONE ACET 200 MG/5 ML.
Who manufactures TRIAMCINOLONE ACET 200 MG/5 ML?
TRIAMCINOLONE ACET 200 MG/5 ML (NDC 00703024301) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.